azd2563 has been researched along with oxazolidin-2-one in 26 studies
Studies (azd2563) | Trials (azd2563) | Recent Studies (post-2010) (azd2563) | Studies (oxazolidin-2-one) | Trials (oxazolidin-2-one) | Recent Studies (post-2010) (oxazolidin-2-one) |
---|---|---|---|---|---|
29 | 0 | 9 | 4,376 | 347 | 1,734 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 19 (73.08) | 29.6817 |
2010's | 6 (23.08) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Anderegg, TR; Biedenbach, DJ; Jones, RN | 4 |
Anderegg, TR; Deshpande, LM; Jones, RN | 1 |
Johnson, AP; Livermore, DM; Warner, M | 1 |
Appelbaum, PC; Clark, CL; Jacobs, MR; Lin, G; Peric, M | 1 |
Appelbaum, PC; Ednie, LM; Jacobs, MR | 1 |
Johnson, AP | 1 |
Fluit, AC; Milatovic, D; Schmitz, FJ; Verhoef, J | 1 |
Baum, SE; Crawford, SA; Jorgensen, JH; McElmeel, ML; Whitney, CG | 1 |
Eliopoulos, GM; Moellering, RC; Wennersten, CB | 1 |
Fluit, AC; Milatovic, D; Schmitz, FJ | 1 |
Anderegg, TR; Jones, RN | 2 |
Johnson, AP; Livermore, DM; Malnick, H; Warner, M | 1 |
Bowker, KE; Howe, RA; MacGowan, AP; Noel, AR; Walsh, TR; Wootton, M | 1 |
Acton, DG; Betts, MJ; Dennis, M; Gravestock, MB; Hatter, G; McGregor, A; Swain, ML; Wilson, RG; Woods, L; Wookey, A | 1 |
Clarke, J; Eastwood, M; Greenhalgh, JM; Sefton, C; Turner, PJ; Wookey, A | 1 |
Jeong, BH; Koh, WJ; Kwon, YS | 1 |
Balasubramanian, V; Cole, ST; Dhar, N; Marriner, G; Sala, C; Sambandamurthy, VK; Sharma, S; Vocat, A; Zhang, M | 1 |
Balasubramanian, V; Hoffner, S; Perskvist, N; Rodrigues, C; Sambandamurthy, VK; Werngren, J; Wijkander, M | 1 |
Balasubramanian, V; Bharath, S; Butler, SL; Deshpande, A; Gaonkar, S; Kumar, N; Mahesh, KN; Melnick, D; Reddy, J; Shandil, R; Solapure, S; Wright, L | 1 |
Barry, CE; Chen, RY; Cho, SN; Coleman, MT; Dartois, V; Dodd, LE; Flynn, JL; Janssen, C; Kim, Y; Klein, E; Lee, M; Lin, PL; Maiello, P; Marriner, G; Scanga, C; Via, LE; Wang, J | 1 |
Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T | 1 |
Karkara, BB; Kumar, A; Panda, G | 1 |
3 review(s) available for azd2563 and oxazolidin-2-one
Article | Year |
---|---|
AZD-2563 AstraZeneca.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Structure-Activity Relationship | 2002 |
Tuberculosis: clinical trials and new drug regimens.
Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches.
Topics: Adamantane; Animals; Antitubercular Agents; DNA Gyrase; Drug Development; Enzyme Inhibitors; Humans; Isonicotinic Acids; Mycobacterium tuberculosis; Oxazolidinones; Piperidines; Pyrroles; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uridine | 2021 |
23 other study(ies) available for azd2563 and oxazolidin-2-one
Article | Year |
---|---|
In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species.
Topics: Anti-Bacterial Agents; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxazolidinones | 2002 |
In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
Topics: Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Oxazolidinones; Streptococcus pyogenes; Viridans Streptococci | 2002 |
AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Streptococcus; Time Factors; Vancomycin | 2002 |
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
Topics: Acetamides; Anti-Bacterial Agents; Coagulase; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Streptococcus pneumoniae | 2002 |
Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Oxazolidinones; Streptococcus pneumoniae | 2002 |
Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxazolidinones | 2002 |
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus | 2002 |
In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Oxazolidinones; Streptococcus | 2002 |
Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Linezolid; Microbial Sensitivity Tests; North America; Oxazolidinones; Pneumococcal Infections; Streptococcus pneumoniae | 2002 |
In vitro activity of the new oxazolidinone AZD2563 against Enterococci.
Topics: Acetamides; Drug Resistance, Bacterial; Enterococcus; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones | 2002 |
The presence of ermB in Streptococcus pneumoniae has no influence on AZD2563 MIC values.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Methyltransferases; Microbial Sensitivity Tests; Oxazolidinones; Streptococcus pneumoniae | 2003 |
Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone.
Topics: Diffusion; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxazolidinones; Quality Control; Sensitivity and Specificity; Staphylococcus aureus; Streptococcus pneumoniae | 2003 |
Activity of the oxazolidinones AZD2563 and linezolid against Corynebacterium jeikeium and other Corynebacterium spp.
Topics: Acetamides; Corynebacterium; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Oxazolidinones | 2003 |
Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinone.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Cocci; Oxazolidinones | 2003 |
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2003 |
New classes of antibacterial oxazolidinones with C-5, methylene O-linked heterocyclic side chains.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Heterocyclic Compounds; Hydrocarbons; Methane; Mice; Microbial Sensitivity Tests; Oxazolidinones; Rats; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2003 |
Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinone.
Topics: Anti-Bacterial Agents; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus | 2004 |
AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro.
Topics: Bacteria; Microbial Sensitivity Tests; Oxazolidinones | 2004 |
In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Cells, Cultured; Colony Count, Microbial; Female; Hypoxia; Latent Tuberculosis; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones | 2014 |
In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Pulmonary | 2014 |
Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis.
Topics: Animals; Area Under Curve; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Pulmonary | 2014 |
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.
Topics: Acetamides; Algorithms; Animals; Anti-Bacterial Agents; Extensively Drug-Resistant Tuberculosis; Fluorodeoxyglucose F18; Humans; Linezolid; Lymph Nodes; Macaca; Multimodal Imaging; Oxazolidinones; Positron-Emission Tomography; Stem Cells; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |